Astellas Pharma Inc. Logo

Astellas Pharma Inc.

A global pharmaceutical company turning innovative science into value for patients.

4503 | T

Overview

Corporate Details

ISIN(s):
JP3942400007
LEI:
Country:
Japan
Address:
中央区日本橋本町二丁目5番1号

Description

Astellas Pharma Inc. is a global pharmaceutical company dedicated to improving human health by turning innovative science into value for patients. The company's core activities encompass the research, development, manufacture, and commercialization of novel pharmaceutical products. Astellas focuses on pioneering transformative therapies in disease areas with high unmet medical needs, including oncology, ophthalmology, urology, immunology, and women's health. Through its patient-centric approach and robust research and development programs, the company aims to deliver innovative healthcare solutions worldwide.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2017-11-08 01:55
四半期報告書-第13期第2四半期(2017/07/01-2017/09/30)
Japanese 200.9 KB
2017-08-07 04:09
四半期報告書-第13期第1四半期(2017/04/01-2017/06/30)
Japanese 175.2 KB
2017-06-19 09:22
有価証券報告書-第12期(2016/04/01-2017/03/31)
Japanese 1.3 MB
2017-02-08 06:44
四半期報告書-第12期第3四半期(2016/10/01-2016/12/31)
Japanese 195.2 KB
2016-11-02 01:36
四半期報告書-第12期第2四半期(2016/07/01-2016/09/30)
Japanese 194.7 KB
2016-08-05 02:04
四半期報告書-第12期第1四半期(2016/04/01-2016/06/30)
Japanese 160.7 KB
2016-06-20 09:18
有価証券報告書-第11期(2015/04/01-2016/03/31)
Japanese 1.3 MB
2016-02-08 01:41
四半期報告書-第11期第3四半期(2015/10/01-2015/12/31)
Japanese 177.8 KB
2015-11-06 01:03
四半期報告書-第11期第2四半期(2015/07/01-2015/09/30)
Japanese 186.3 KB

Automate Your Workflow. Get a real-time feed of all Astellas Pharma Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Astellas Pharma Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Astellas Pharma Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.